Literature DB >> 10500096

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

X Zhang1, V Mar, W Zhou, L Harrington, M O Robinson.   

Abstract

Despite a strong correlation between telomerase activity and malignancy, the outcome of telomerase inhibition in human tumor cells has not been examined. Here, we have addressed the role of telomerase activity in the proliferation of human tumor and immortal cells by inhibiting TERT function. Inducible dominant-negative mutants of hTERT dramatically reduced the level of endogenous telomerase activity in tumor cell lines. Clones with short telomeres continued to divide, then exhibited an increase in abnormal mitoses followed by massive apoptosis leading to the loss of the entire population. This cell death was telomere-length dependent, as cells with long telomeres were viable but exhibited telomere shortening at a rate similar to that of mortal cells. It appears that telomerase inhibition in cells with short telomeres lead to chromosomal damage, which in turn trigger apoptotic cell death. These results provide the first direct evidence that telomerase is required for the maintenance of human tumor and immortal cell viability, and suggest that tumors with short telomeres may be effectively and rapidly killed following telomerase inhibition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500096      PMCID: PMC317024          DOI: 10.1101/gad.13.18.2388

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  40 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

3.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  The catalytic subunit of yeast telomerase.

Authors:  C M Counter; M Meyerson; E N Eaton; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.

Authors:  A Kilian; D D Bowtell; H E Abud; G R Hime; D J Venter; P K Keese; E L Duncan; R R Reddel; R A Jefferson
Journal:  Hum Mol Genet       Date:  1997-11       Impact factor: 6.150

Review 6.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

7.  Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.

Authors:  R A Greenberg; L Chin; A Femino; K H Lee; G J Gottlieb; R H Singer; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

Review 8.  Telomere dynamics and telomerase activity in in vitro immortalised human cells.

Authors:  T M Bryan; R R Reddel
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

9.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

10.  TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family.

Authors:  J Nakayama; M Saito; H Nakamura; A Matsuura; F Ishikawa
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

View more
  152 in total

1.  The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function.

Authors:  W Fu; M Killen; C Culmsee; S Dhar; T K Pandita; M P Mattson
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

2.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.

Authors:  L M Colgin; C Wilkinson; A Englezou; A Kilian; M O Robinson; R R Reddel
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

4.  Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

5.  Template definition by Tetrahymena telomerase reverse transcriptase.

Authors:  M C Miller; J K Liu; K Collins
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

6.  Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres.

Authors:  E Samper; J M Flores; M A Blasco
Journal:  EMBO Rep       Date:  2001-08-23       Impact factor: 8.807

Review 7.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

8.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.

Authors:  J F Riou; L Guittat; P Mailliet; A Laoui; E Renou; O Petitgenet; F Mégnin-Chanet; C Hélène; J L Mergny
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

9.  Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert.

Authors:  Yie Liu; Hue Kha; Mark Ungrin; Murray O Robinson; Lea Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

10.  Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.

Authors:  K Perrem; L M Colgin; A A Neumann; T R Yeager; R R Reddel
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.